Literature DB >> 20229318

Quantitative structure-activity relationship study of antitubercular fluoroquinolones.

Nikola Minovski1, Marjan Vračko, Tom Solmajer.   

Abstract

Quantitative structure-activity relationship study on three diverse sets of structurally similar fluoroquinolones was performed using a comprehensive set of molecular descriptors. Multiple linear regression technique was applied as a preprocessing tool to find the set of relevant descriptors (10) which are subsequently used in the artificial neural networks approach (non-linear procedure). The biological activity in the series (minimal inhibitory concentration (μg/mL) was treated as negative decade logarithm, pMIC). Using the non-linear technique counter propagation artificial neural networks, we obtained good predictive models. All models were validated using cross validation leave-one-out procedure. The results (the best models: Assay1, R = 0.8108; Assay2, R = 0.8454, and Assay3, R = 0.9212) obtained on external, previously excluded test datasets show the ability of these models in providing structure-activity relationship of fluoroquinolones. Thus, we demonstrated the advantage of non-linear approach in prediction of biological activity in these series. Furthermore, these validated models could be proficiently used for the design of novel structurally similar fluoroquinolone analogues with potentially higher activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20229318     DOI: 10.1007/s11030-010-9238-5

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  25 in total

Review 1.  DNA topoisomerases: structure, function, and mechanism.

Authors:  J J Champoux
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 2.  Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents.

Authors:  Lester A Mitscher
Journal:  Chem Rev       Date:  2005-02       Impact factor: 60.622

3.  Validation of counter propagation neural network models for predictive toxicology according to the OECD principles: a case study.

Authors:  M Vracko; V Bandelj; P Barbieri; E Benfenati; Q Chaudhry; M Cronin; J Devillers; A Gallegos; G Gini; P Gramatica; C Helma; P Mazzatorta; D Neagu; T Netzeva; M Pavan; G Patlewicz; M Randić; I Tsakovska; A Worth
Journal:  SAR QSAR Environ Res       Date:  2006-06       Impact factor: 3.000

Review 4.  Clinical use of the fluoroquinolones.

Authors:  R C Owens; P G Ambrose
Journal:  Med Clin North Am       Date:  2000-11       Impact factor: 5.456

Review 5.  Mechanisms of action of antimicrobials: focus on fluoroquinolones.

Authors:  D C Hooper
Journal:  Clin Infect Dis       Date:  2001-03-15       Impact factor: 9.079

Review 6.  Quinolone-based drugs against Toxoplasma gondii and Plasmodium spp.

Authors:  Guillaume Anquetin; Jacques Greiner; Pierre Vierling
Journal:  Curr Drug Targets Infect Disord       Date:  2005-09

Review 7.  Antituberculosis drugs: ten years of research.

Authors:  Yves L Janin
Journal:  Bioorg Med Chem       Date:  2007-01-19       Impact factor: 3.641

Review 8.  DNA gyrase: structure and function.

Authors:  R J Reece; A Maxwell
Journal:  Crit Rev Biochem Mol Biol       Date:  1991       Impact factor: 8.250

Review 9.  Fluoroquinolones as chemotherapeutics against mycobacterial infections.

Authors:  Michael R Jacobs
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

Review 10.  Emerging mechanisms of fluoroquinolone resistance.

Authors:  D C Hooper
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  2 in total

1.  Combinatorially-generated library of 6-fluoroquinolone analogs as potential novel antitubercular agents: a chemometric and molecular modeling assessment.

Authors:  Nikola Minovski; Andrej Perdih; Tom Solmajer
Journal:  J Mol Model       Date:  2011-08-12       Impact factor: 1.810

2.  The structural modeling of the interaction between levofloxacin and the Mycobacterium tuberculosis gyrase catalytic site sheds light on the mechanisms of fluoroquinolones resistant tuberculosis in Colombian clinical isolates.

Authors:  N Alvarez; E Zapata; G I Mejía; T Realpe; P Araque; C Peláez; F Rouzaud; J Robledo
Journal:  Biomed Res Int       Date:  2014-04-28       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.